Neurohumoral Compensatory Mechanisms

The activation of neurohumoral compensatory mechanisms is a common physiological phenomenon in heart failure in order to make up for a failing heart, which will usually have a deteriorating effect on overall health condition. Discover the latest research on Neurohumoral Compensatory Mechanisms here.

January 16, 2021
Open Access

Adrenomedullin and Its Possible Role in Improved Survival in Female Patients with Sepsis: A Study in the South East Asian Region

Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine
Mradul K DagaTarun Kumar Mishra
January 9, 2021
Review
Open Access

Autonomic Modulation for Cardiovascular Disease

Frontiers in Physiology
Joseph Hadaya, Jeffrey L Ardell
January 17, 2021

Spontaneous Synchronous Network Activity in the Neonatal Development of mPFC in Mice

Developmental Neurobiology
Johny PiresRhiannon M Meredith
January 14, 2021

Impact of diabetes on serum biomarkers in heart failure with preserved ejection fraction: insights from the TOPCAT trial

ESC Heart Failure
Corrado De MarcoEileen O'Meara
January 6, 2021
Open Access

Effect of frailty on treatment, hospitalisation and death in patients with chronic heart failure

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
S SzeA L Clark
January 17, 2021

Sacubitril/valsartan in the treatment of systemic right ventricular failure

Heart
Tjitske E ZandstraAnastasia D Egorova
January 7, 2021

AMPAr GluA1 Phosphorylation at Serine 845 in Limbic System Is Associated with Cardiac Autonomic Tone

Molecular Neurobiology
Hiago Murilo MeloRoger Walz
January 13, 2021
Review
Open Access

Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence

Journal of Clinical Medicine
Eleni-Evangelia KoufouAndreas P Kalogeropoulos
January 6, 2021

Impella CP and ProtekDuo as a bridge to recovery following surgical revascularization complicated by electrical storm

General Thoracic and Cardiovascular Surgery
Pierpaolo ChivassoSeverino Iesu
January 16, 2021

Evaluation of the safety and tolerability of spironolactone in patients with heart failure and chronic kidney disease

European Journal of Clinical Pharmacology
Amanda R BuckallewAnastasia L Armbruster
January 11, 2021
Review

Do neprilysin inhibitors walk the line? Heart ameliorative but brain threatening!

European Journal of Pharmacology
Elnaz PoorgolizadehMohammad Hossein Nasr-Esfahani
January 6, 2021
Review
Open Access

Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases

Clinical Science
Ravindra K SharmaRajesh Mohandas
January 15, 2021
Open Access

Crossing the chasm: caution for use of angiotensin receptor-neprilysin inhibition in patients with cardiogenic shock- a case report

European Heart Journal. Case Reports
Loai AlmazroaAdriana Luk

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved
/feed-previews/neurohumoral-compensatory-mechanisms/d1d63849-0651-4e13-96af-91a8aaae1728